Zobrazeno 1 - 10
of 491
pro vyhledávání: '"Fadilah S"'
Autor:
Ghalia Shamlan, Mohammed Albreiki, Hadeel O. Almasoudi, Lina A. Alshehri, Mazen M. Ghaith, Abdulrahman S. Alharthi, Fadilah S. Aleanizy
Publikováno v:
Journal of Infection and Public Health, Vol 17, Iss 2, Pp 372-377 (2024)
Background: Long-term effects of COVID-19 showed a wide range of symptoms. Also, it was found that older patients were five times more likely than younger patients to develop long-COVID symptoms (1). This study aimed to investigate the use of Nutriti
Externí odkaz:
https://doaj.org/article/1294d41a98e040ceb04240abfeba8e15
Publikováno v:
Saudi Pharmaceutical Journal, Vol 32, Iss 6, Pp 102063- (2024)
Purpose: Isotretinoin (ITN) is a poorly water-soluble drug. The objective of this study was to design a successful liquid self-nanoemulsifying drug delivery system (L-SNEDDS) for ITN to improve its solubility, dissolution rate, and antibacterial acti
Externí odkaz:
https://doaj.org/article/c72429db5b644c65a9923a69fd7875f7
Autor:
Rihaf Alfaraj, Esra K. Eltayb, Bashayer M. AlFayez, Amjad Abohamad, Eram Eltahir, Naifa A. Alenazi, Sandra Hababah, Hamad Alkahtani, Thamer A. Almangour, Fulwah Y. Alqahtani, Fadilah S. Aleanizy
Publikováno v:
Microbiology Research, Vol 14, Iss 4, Pp 1596-1609 (2023)
Quorum-sensing inhibitors have recently garnered great interest, as they reduce bacterial virulence, lower the probability of resistance, and inhibit infections. In this work, meta-bromo-thiolactone (mBTL), a potent quorum and virulence inhibitor of
Externí odkaz:
https://doaj.org/article/cde3c8071e8345e7af97105d6fe3593f
Publikováno v:
In Saudi Pharmaceutical Journal June 2024 32(6)
Autor:
Alenazi, Naifa A., Aleanizy, Fadilah S., Alqahtani, Fulwah Y., Aldossari, Abdullah A., Alanazi, Mohammed M., Alfaraj, Rihaf
Publikováno v:
In Saudi Pharmaceutical Journal February 2024 32(2)
Autor:
Shamlan, Ghalia, Albreiki, Mohammed, Almasoudi, Hadeel O., Alshehri, Lina A., Ghaith, Mazen M., Alharthi, Abdulrahman S., Aleanizy, Fadilah S.
Publikováno v:
In Journal of Infection and Public Health February 2024 17(2):372-377
Autor:
Naifa A. Alenazi, Fadilah S. Aleanizy, Fulwah Y. Alqahtani, Abdullah A. Aldossari, Mohammed M. Alanazi, Rihaf Alfaraj
Publikováno v:
Saudi Pharmaceutical Journal, Vol 32, Iss 2, Pp 101932- (2024)
Methicillin-resistant Staphylococcus aureus (MRSA) is a significant concern in both healthcare and community settings, as it causes numerous infections worldwide with high morbidity and mortality rates. One promising strategy is to target the quorum
Externí odkaz:
https://doaj.org/article/ce2af07f349f4e69ba53178dc691b3c1
Autor:
Bushra T. AlQuadeib, Fadilah S. Aleanizy, Fulwah Y. Alqahtani, Rehab A. Alshammari, Amal Aldarwesh, Ibrahim Alsarra
Publikováno v:
Saudi Pharmaceutical Journal, Vol 31, Iss 4, Pp 547-553 (2023)
Background: Ruboxistaurin (RBX) used to treat retinopathy in diabetic patients which caused by microvascular damage and leakage which contributes to visual loss. There are no published studies on the use of liquid chromatography-tandem mass spectrome
Externí odkaz:
https://doaj.org/article/2b2712f1e9d74fb88e4cdeaffb789388
Autor:
Fatani, Wafa K.1 (AUTHOR), Aleanizy, Fadilah S.1 (AUTHOR), Alqahtani, Fulwah Y.1 (AUTHOR), Alanazi, Mohammed M.2 (AUTHOR), Aldossari, Abdullah A.2 (AUTHOR), Shakeel, Faiyaz1 (AUTHOR), Haq, Nazrul1 (AUTHOR), Abdelhady, Hosam3 (AUTHOR), Alkahtani, Hamad M.4 (AUTHOR), Alsarra, Ibrahim A.1 (AUTHOR) ialsarra@ksu.edu.sa
Publikováno v:
Molecules. May2023, Vol. 28 Issue 9, p3974. 14p.
Publikováno v:
Saudi Pharmaceutical Journal, Vol 29, Iss 12, Pp 1492-1497 (2021)
Objectives: Antimicrobial resistance is one of the main global problems faced by healthcare institutions. Healthcare professionals as service providers must have a basic understanding of this emerging threat; additionally, considering the evolving ro
Externí odkaz:
https://doaj.org/article/0f96fdb2113d4b788f330d8eac4183b6